ENTO

Entero Therapeutics

16 hedge funds and large institutions have $1.29M invested in Entero Therapeutics in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 5 closing their positions.

Holders
16
Holders Change
-2
Holders Change %
-11.11%
% of All Funds
0.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
5
Reduced
4
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$623K 687,164 -11,374 -2%
PCM
2
Parsons Capital Management
Rhode Island
$161K 178,203 -104,257 -37%
Renaissance Technologies
3
Renaissance Technologies
New York
$130K 143,500 +131,000 +1,048%
WIA
4
World Investment Advisors
California
$90K 80,000 +30,000 +60%
WPW
5
Waldron Private Wealth
Pennsylvania
$63K 69,835
TA
6
Tiedemann Advisors
New York
$57K 63,460
Geode Capital Management
7
Geode Capital Management
Massachusetts
$39K 43,085
Squarepoint
8
Squarepoint
New York
$36K 39,439 +39,439 New
AAP
9
Ardsley Advisory Partners
Connecticut
$27K 30,000
Northern Trust
10
Northern Trust
Illinois
$21K 23,019 -178 -0.8%
BlackRock
11
BlackRock
New York
$14K 15,332 -47,374 -76%
PFGIA
12
Patriot Financial Group Insurance Agency
Massachusetts
$14K 15,250 +7,500 +97%
TRCT
13
Tower Research Capital (TRC)
New York
$14K 15,557 +15,557 New
HFM
14
Hartford Financial Management
Connecticut
$1K 1,000 +1,000 New
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
-27,868 Closed
RC
16
RegentAtlantic Capital
New Jersey
-20,000 Closed
Citadel Advisors
17
Citadel Advisors
Florida
-11,829 Closed
Victory Capital Management
18
Victory Capital Management
Texas
-8,264 Closed
UBS Group
19
UBS Group
Switzerland
-1,425 Closed
CFGS
20
Concourse Financial Group Securities
Alabama
Wells Fargo
21
Wells Fargo
California
$0 127 +1 +0.8%
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$0 282 +66 +31%